Hair and Nail Disorders

On this page

🔬 The Dermatological Detective's Arsenal: Hair and Nail Disorder Mastery

Hair and nail disorders reveal far more than cosmetic concerns-they serve as windows into systemic disease, nutritional deficiencies, autoimmune processes, and genetic conditions that demand your diagnostic acumen. You'll master the molecular mechanisms driving these disorders, build pattern recognition skills to distinguish alopecia areata from tinea capitis or psoriatic nails from onychomycosis, and deploy evidence-based treatment algorithms that address both local pathology and underlying systemic triggers. By integrating dermatologic findings with multi-system clinical correlations, you'll transform subtle changes in keratin structures into actionable diagnoses that can alter patient outcomes.

Detailed microscopic view of hair follicle anatomy showing all growth phases

📌 Remember: HAIRS - Hormones (androgens), Autoimmune (alopecia areata), Infections (tinea), Reactive (telogen effluvium), Scarring (lichen planopilaris). These five categories encompass >95% of hair loss presentations in clinical practice.

The diagnostic approach to hair and nail disorders demands systematic evaluation of growth patterns, morphological characteristics, and associated systemic findings. Master clinicians recognize that 80% of hair disorders present with characteristic patterns visible on clinical examination, while 20% require dermoscopy, trichoscopy, or histopathological confirmation.

Clinical Pearl: Hair pull tests yield >10 hairs in active telogen effluvium, <3 hairs in normal conditions, and 0-2 hairs in established androgenetic alopecia. This simple bedside test provides 85% diagnostic accuracy for differentiating acute versus chronic hair loss patterns.

  • Androgenetic Alopecia: Affects 50% of men by age 50, follows predictable Hamilton-Norwood patterns

    • DHT sensitivity increases 5-fold in genetically susceptible follicles
    • Miniaturization process occurs over 2-5 years per follicular unit
    • Treatment response rates: Finasteride 83%, Minoxidil 65%, combination therapy 91%
  • Telogen Effluvium: Triggered 2-4 months after inciting event

    • Normal daily hair loss: 50-100 hairs, TE increases to >300 hairs/day
    • Recovery timeline: 6-12 months with trigger removal
    • Chronic TE affects 12% of women over age 40
  • Alopecia Areata: Autoimmune condition affecting 2% of population

    • Nail involvement occurs in 44% of cases (geometric pitting pattern)
    • Progression to totalis/universalis: 7% of patients
    • Spontaneous recovery within 1 year: 80% for limited patches

Comprehensive nail anatomy diagram showing matrix, bed, and surrounding structures

💡 Master This: Nail growth rates vary by digit - thumbnails grow 3mm/month, fingernails 2.5mm/month, toenails 1mm/month. Complete nail replacement requires 6 months for fingernails, 12-18 months for toenails. Understanding these timelines predicts when therapeutic changes become visible and guides treatment duration expectations.

Connect these foundational patterns through systematic clinical evaluation to understand how morphological changes reveal underlying pathophysiology and guide targeted therapeutic interventions.

🔬 The Dermatological Detective's Arsenal: Hair and Nail Disorder Mastery

⚡ The Pathophysiology Powerhouse: Molecular Mechanisms Driving Disorder

📌 Remember: CYCLES - Catagen (regression 2-3 weeks), Youth phase (anagen 2-7 years), Cessation (telogen 3 months), Length determines by anagen duration, Exogen (active shedding), Synchronization disruption causes effluvium. Normal follicles cycle independently; pathological conditions synchronize cycling patterns.

The androgenetic alopecia pathway demonstrates how 5α-reductase converts testosterone to DHT, which binds androgen receptors with 10-fold higher affinity than testosterone. This binding activates transcription factors that upregulate TGF-β1 expression by 300%, leading to follicular miniaturization over 20-25 cycles. Understanding this cascade explains why 5α-reductase inhibitors prevent 83% of further hair loss and why treatment requires 6-12 months to show visible results.

Clinical Pearl: Nail matrix cells divide every 12-24 hours, making nails sensitive indicators of systemic disease. Beau's lines appear 2-4 weeks after illness onset, with 1mm of nail growth representing approximately 1 month of time. This temporal relationship allows precise dating of systemic insults.

  • Autoimmune Mechanisms: Alopecia areata involves CD8+ T-cell infiltration around follicular bulbs

    • IL-15 and IFN-γ levels increase 5-10 fold in affected areas
    • JAK-STAT pathway activation drives inflammatory cascade
    • NK cells comprise 40% of perifollicular infiltrate in active lesions
    • Nail involvement correlates with HLA-DQB1*03 allele presence
  • Infectious Pathophysiology: Dermatophyte invasion follows predictable patterns

    • Trichophyton rubrum accounts for 80% of onychomycosis cases
    • Fungal invasion rate: 0.5mm/month in nail plate
    • Keratinase production allows keratin degradation and tissue invasion
    • Biofilm formation increases treatment resistance by 60%

💡 Master This: The hair follicle immune privilege depends on MHC class I downregulation and immunosuppressive factors like TGF-β and α-MSH. When this privilege collapses in alopecia areata, CD8+ T-cells recognize follicular antigens as foreign, creating the "swarm of bees" histological pattern around anagen bulbs.

PathwayKey MediatorTimelineClinical MarkerTreatment Target
AndrogeneticDHT/AR complex2-5 yearsProgressive thinning5α-reductase
AutoimmuneCD8+ T-cells2-6 monthsPatchy lossJAK inhibitors
InflammatoryTNF-α/IL-1β1-3 monthsScarringImmunosuppression
InfectiousKeratinases6-12 monthsNail dystrophyAntifungals
MetabolicGrowth factors2-4 monthsDiffuse thinningNutritional support

⚡ The Pathophysiology Powerhouse: Molecular Mechanisms Driving Disorder

🎯 The Clinical Pattern Recognition Matrix: Diagnostic Frameworks

Clinical photograph showing typical male pattern baldness Hamilton-Norwood classification

📌 Remember: PATTERN - Progressive (androgenetic), Acute onset (telogen effluvium), Total loss (alopecia totalis), Terminal hair affected (androgenetic), Exclamation point hairs (alopecia areata), Receding hairline (male pattern), Nail changes (systemic disease). Each pattern points to specific diagnostic categories with >90% accuracy.

The systematic approach to hair loss evaluation follows a hierarchical decision tree that rapidly narrows differential diagnosis. Distribution pattern provides the first diagnostic clue: diffuse thinning suggests telogen effluvium or female pattern hair loss, patchy loss indicates alopecia areata or trichotillomania, scarring points to cicatricial alopecias, and patterned loss confirms androgenetic alopecia.

  • Androgenetic Alopecia Recognition Patterns:

    • Male pattern: M-shaped recession, vertex thinning, Hamilton-Norwood stages I-VII
    • Female pattern: Christmas tree distribution, crown thinning, Ludwig grades I-III
    • Dermoscopy findings: >20% diameter variation, yellow dots, peripilar signs
    • Pull test: <3 hairs extracted (vs >10 in telogen effluvium)
  • Alopecia Areata Diagnostic Framework:

    • Exclamation point hairs: 2-3mm broken hairs with tapered proximal ends
    • Geometric nail pitting: 20-nail dystrophy in 44% of cases
    • Ophiasis pattern: Band-like loss along occipital/temporal margins
    • Sisaipho pattern: Central scalp sparing with peripheral loss

Dermoscopy image showing exclamation point hairs characteristic of alopecia areata

Clinical Pearl: The hair pull test provides 85% diagnostic accuracy when performed correctly. Extract 50-60 hairs from 3 different scalp areas using firm traction. Normal result: <3 hairs/pull. Positive test (>10 hairs) indicates active hair shedding phase, distinguishing telogen effluvium from androgenetic alopecia with high specificity.

  • Nail Disorder Pattern Recognition:
    • Longitudinal ridging: Normal aging vs lichen planus (severe ridging with pterygium)
    • Pitting patterns: Psoriasis (irregular, >20 pits/nail) vs alopecia areata (geometric, uniform)
    • Color changes: Yellow nail syndrome (slow growth, <0.5mm/month) vs onychomycosis (distal progression)
    • Thickness changes: Pachyonychia congenita (uniform thickening) vs onychomycosis (irregular dystrophy)

💡 Master This: Dermoscopy magnification reveals diagnostic features invisible to naked eye examination. Yellow dots (empty follicular openings) indicate follicular destruction in alopecia areata. Peripilar signs (brown halos around follicles) suggest androgenetic alopecia. Black dots (broken hair shafts) point to trichotillomania or tinea capitis.

Clinical SignPrimary AssociationSensitivitySpecificityAdditional Features
Exclamation point hairsAlopecia areata85%95%2-3mm length, tapered base
Yellow dotsFollicular destruction78%89%Empty follicular openings
Geometric pittingAlopecia areata44%92%Uniform pit distribution
Christmas tree patternFemale androgenetic76%88%Central part widening
Ophiasis patternSevere alopecia areata12%98%Band-like occipital loss

🎯 The Clinical Pattern Recognition Matrix: Diagnostic Frameworks

🔍 The Differential Diagnosis Decoder: Systematic Discrimination

📌 Remember: DIFFERS - Distribution (focal vs diffuse), Inflammation (present vs absent), Follicular involvement (scarring vs non-scarring), Family history (genetic vs acquired), Exacerbating factors (hormonal vs environmental), Recovery pattern (spontaneous vs progressive), Systemic associations (isolated vs multisystem). These seven parameters discriminate >95% of hair loss differentials.

The systematic approach to differential diagnosis employs quantitative discriminators that provide objective separation between overlapping conditions. Temporal patterns offer the first level of discrimination: acute onset (<6 months) suggests telogen effluvium or alopecia areata, gradual progression (>2 years) indicates androgenetic alopecia, and rapid progression (<3 months) points to severe systemic disease or cicatricial alopecia.

  • Telogen Effluvium vs Female Pattern Hair Loss:

    • Onset timing: TE follows trigger by 2-4 months, FPHL develops over years
    • Hair pull test: TE yields >10 hairs, FPHL yields <3 hairs
    • Distribution: TE affects entire scalp uniformly, FPHL shows Christmas tree pattern
    • Recovery: TE resolves in 6-12 months, FPHL progresses without treatment
    • Dermoscopy: TE shows uniform hair diameter, FPHL shows >20% diameter variation
  • Alopecia Areata vs Trichotillomania:

    • Hair shaft examination: AA shows exclamation point hairs, TTM shows broken irregular lengths
    • Follicular involvement: AA preserves follicular openings, TTM may show follicular hemorrhage
    • Pattern: AA creates round/oval patches, TTM shows irregular geometric shapes
    • Nail changes: AA shows geometric pitting in 44%, TTM rarely affects nails
    • Trichoscopy: AA shows yellow dots and black dots, TTM shows coiled hairs

Dermoscopy comparison showing yellow dots in alopecia areata versus broken hairs in trichotillomania

Clinical Pearl: Biopsy timing critically affects diagnostic accuracy. In suspected alopecia areata, biopsy active borders showing exclamation point hairs, not central bald areas. In cicatricial alopecia, target erythematous advancing edges where inflammation is most active. Proper site selection increases diagnostic yield from 60% to >90%.

  • Onychomycosis vs Psoriatic Nail Disease:
    • Progression pattern: Onychomycosis starts distally, psoriasis affects multiple nails simultaneously
    • Nail plate changes: Onychomycosis shows yellow-brown discoloration, psoriasis shows oil drop sign
    • Pitting pattern: Onychomycosis rarely pits, psoriasis shows irregular deep pits
    • KOH examination: Onychomycosis shows hyphae/spores, psoriasis negative
    • Response to antifungals: Onychomycosis improves >80%, psoriasis shows no response

💡 Master This: Laboratory correlation provides definitive discrimination when clinical features overlap. KOH examination has 80% sensitivity for onychomycosis but 95% specificity. Fungal culture requires 4-6 weeks but provides species identification and antifungal sensitivity. PCR testing offers 95% sensitivity with 48-hour results but costs 3-fold more than culture.

ConditionOnset PatternDistributionHair Pull TestDermoscopy FindingsRecovery Pattern
Telogen EffluviumAcute (2-4 months)Diffuse uniform>10 hairsUniform diameter6-12 months
Androgenetic AlopeciaGradual (years)Patterned<3 hairs>20% variationProgressive
Alopecia AreataSubacute (weeks)Patchy roundVariableYellow/black dots80% in 1 year
TrichotillomaniaVariableIrregular patches<5 hairsBroken hairsWith behavior change
Tinea CapitisGradual (months)Patchy with scale>5 hairsComma hairsWith antifungals

🔍 The Differential Diagnosis Decoder: Systematic Discrimination

⚖️ The Treatment Algorithm Engine: Evidence-Based Therapeutic Decisions

Clinical photograph showing before and after results of finasteride treatment for androgenetic alopecia

📌 Remember: THERAPY - Timing (early intervention improves outcomes), Hormonal status (affects drug selection), Efficacy data (evidence-based choices), Risk factors (contraindications), Adherence potential (realistic regimens), Patient preferences (lifestyle factors), Yield expectations (realistic goals). These seven factors determine treatment success rates and patient satisfaction.

The systematic approach to treatment selection employs evidence-based algorithms that match therapeutic mechanisms to disease pathophysiology. First-line therapies demonstrate >70% efficacy with acceptable safety profiles, second-line options target refractory cases or specific patient populations, and combination therapies achieve synergistic effects with 15-25% improved response rates over monotherapy.

  • Androgenetic Alopecia Treatment Algorithm:

    • First-line male: Finasteride 1mg daily (83% stabilization, 65% improvement)
    • First-line female: Minoxidil 5% twice daily (60% response rate)
    • Combination therapy: Finasteride + Minoxidil achieves 91% response rate
    • Refractory cases: Dutasteride 0.5mg daily (89% response in finasteride failures)
    • Adjuvant therapy: Low-level laser therapy adds 15% improvement to medical therapy
  • Alopecia Areata Treatment Hierarchy:

    • Limited patches (<50% scalp): Intralesional corticosteroids (60-70% response)
    • Extensive disease: Topical immunotherapy (DPCP/SADBE) (40-60% response)
    • Severe/refractory: JAK inhibitors (tofacitinib) (60-80% response in trials)
    • Pediatric cases: Topical corticosteroids + minoxidil (50% response)
    • Maintenance therapy: Topical calcineurin inhibitors reduce relapse by 40%

Clinical Pearl: Treatment duration critically affects success rates. Androgenetic alopecia requires 6-12 months to show visible improvement, with maximum benefit at 24 months. Discontinuing therapy results in return to baseline within 12 months. Setting realistic expectations prevents premature treatment abandonment and improves long-term outcomes.

  • Onychomycosis Treatment Protocols:
    • Mild disease (<50% nail involvement): Topical therapy (efinaconazole 17.8% cure rate)
    • Moderate disease: Oral terbinafine 250mg daily for 12 weeks (76% cure rate)
    • Severe/refractory: Combination therapy (oral + topical) (85% cure rate)
    • Pulse therapy: Itraconazole 400mg daily for 1 week/month × 3 months (63% cure)
    • Laser adjuvant: Nd:YAG laser + oral therapy improves cure rates by 20%

💡 Master This: Biomarker monitoring optimizes treatment outcomes and prevents adverse effects. DHT levels decrease 65% with finasteride, 90% with dutasteride. Liver function tests should be monitored with oral antifungals every 4-6 weeks. Complete blood counts are essential with JAK inhibitors due to immunosuppressive effects.

ConditionFirst-Line TreatmentResponse RateTime to ResponseMaintenance RequiredAlternative Options
Male AGAFinasteride 1mg daily83% stabilization6-12 monthsContinuousDutasteride, transplant
Female AGAMinoxidil 5% BID60% improvement4-6 monthsContinuousSpironolactone, laser
Alopecia AreataIntralesional steroids60-70% regrowth2-3 monthsPRNTopical immunotherapy
OnychomycosisTerbinafine 250mg76% cure3-6 monthsNoneItraconazole, topicals
Telogen EffluviumTrigger removal90% recovery6-12 monthsNoneMinoxidil, supplements

⚖️ The Treatment Algorithm Engine: Evidence-Based Therapeutic Decisions

🔗 The Multi-System Integration Hub: Advanced Clinical Correlations

📌 Remember: SYSTEMS - Systemic lupus (diffuse hair loss), Yellow nail syndrome (lymphatic dysfunction), Sclerodactyly (nail fold changes), Thyroid disease (hair texture changes), Endocrine disorders (hirsutism patterns), Malnutrition (multiple deficiencies), Sarcoidal granulomas (scarring alopecia). These systemic associations guide comprehensive evaluation and reveal underlying pathophysiology.

The integration of hair and nail findings with systemic disease follows predictable patterns that enhance diagnostic accuracy and reveal disease activity. Autoimmune conditions affect hair and nails in 60-80% of cases, endocrine disorders create characteristic patterns in >90% of patients, and nutritional deficiencies manifest dermatologically before systemic symptoms in 70% of cases.

  • Endocrine-Hair Integration Patterns:

    • Hypothyroidism: Hair becomes coarse, dry, brittle with prolonged telogen phase
    • Hyperthyroidism: Diffuse thinning with shortened anagen phase and increased shedding
    • PCOS: Androgenetic pattern hair loss with hirsutism (Ferriman-Gallwey score >8)
    • Cushing's syndrome: Purple striae with proximal muscle weakness and moon facies
    • Addison's disease: Hyperpigmentation of nail beds and diffuse hair loss
  • Autoimmune-Nail Correlations:

    • Systemic lupus: Periungual erythema and nail fold capillary changes in 85%
    • Scleroderma: Nail fold capillary dilation and digital ulcerations in 95%
    • Dermatomyositis: Gottron's papules and periungual telangiectasias in 90%
    • Psoriatic arthritis: Nail involvement precedes joint symptoms in 40% of cases
    • Alopecia areata: Associated with thyroid disease (20%), vitiligo (4%), diabetes (2%)

Clinical photograph showing nail fold capillary changes in systemic sclerosis

Clinical Pearl: Nail fold capillaroscopy reveals systemic autoimmune disease with 95% specificity. Giant capillary loops (>50 micrometers) indicate scleroderma spectrum disorders. Capillary dropout correlates with digital ulceration risk and pulmonary hypertension development. This simple office procedure provides systemic disease monitoring capabilities.

  • Nutritional-Hair Relationships:
    • Iron deficiency: Diffuse hair loss when ferritin <40 ng/mL (even without anemia)
    • Zinc deficiency: Acrodermatitis enteropathica pattern with perioral dermatitis
    • Biotin deficiency: Brittle hair and nail splitting with lactic acidosis
    • Protein malnutrition: Flag sign (alternating bands) and kwashiorkor changes
    • Essential fatty acids: Dry, brittle hair with scaling dermatitis

💡 Master This: Genetic syndromes create pathognomonic hair and nail patterns that enable early diagnosis. Pachyonychia congenita shows focal palmoplantar keratoderma with thick nails from birth. Ectodermal dysplasias combine sparse hair, absent teeth, and dystrophic nails. Monilethrix creates beaded hair shafts with regular constrictions every 0.7-1mm.

SystemHair ManifestationNail ManifestationAssociated FindingsDiagnostic TestTreatment Impact
ThyroidTexture changes, thinningOnycholysis, ridgingWeight, temperature changesTSH, T3, T4Hormone replacement
AutoimmunePatchy loss, scarringPitting, pterygiumJoint pain, rashesANA, specific antibodiesImmunosuppression
NutritionalDiffuse thinning, brittleSplitting, ridgingFatigue, poor wound healingFerritin, B12, zincTargeted supplementation
GeneticStructural abnormalitiesDystrophy from birthDevelopmental anomaliesGenetic testingSupportive care
InfectiousInflammatory lossDystrophy, discolorationFever, lymphadenopathyCulture, PCRAntimicrobial therapy

🔗 The Multi-System Integration Hub: Advanced Clinical Correlations

🎯 The Clinical Mastery Arsenal: Rapid-Fire Diagnostic Tools

📌 Remember: RAPID - Recognize pattern (distribution/morphology), Assess timeline (acute vs chronic), Perform targeted tests (pull test/dermoscopy), Identify systemic clues (associated findings), Determine treatment urgency (progressive vs stable). This 5-step framework provides >85% diagnostic accuracy in <5 minutes of clinical evaluation.

  • Essential Clinical Arsenal:
    • Hair Pull Test: >10 hairs = active shedding (85% sensitivity for telogen effluvium)
    • Dermoscopy Findings: Yellow dots (alopecia areata), peripilar signs (androgenetic alopecia)
    • Nail Examination: Geometric pitting (alopecia areata), oil drop sign (psoriasis)
    • Temporal Correlation: 2-4 month delay (telogen effluvium), gradual progression (androgenetic)
    • Family History: 50% concordance in androgenetic alopecia, 20% in alopecia areata

Clinical Pearl: The 3-2-1 Rule for urgent referral: 3 months of rapid progression, 2 systems involved (hair + nails), 1 red flag sign (scarring, systemic symptoms, or treatment resistance). This framework identifies >95% of cases requiring immediate specialist evaluation or systemic workup.

💡 Master This: Pattern + Timeline + Response creates diagnostic certainty. Androgenetic alopecia shows patterned loss over years with poor response to anti-inflammatory treatments. Alopecia areata demonstrates patchy loss over months with variable spontaneous recovery. Telogen effluvium presents diffuse loss over weeks with excellent recovery after trigger removal.

Clinical ToolDiagnostic TargetSensitivitySpecificityTime RequiredClinical Utility
Hair Pull TestActive shedding85%90%30 secondsTelogen effluvium screening
DermoscopyPattern recognition90%85%2 minutesDifferential diagnosis
Nail ExaminationSystemic disease75%95%1 minuteAutoimmune screening
Timeline AnalysisEtiology classification80%88%30 secondsRapid triage
Family HistoryGenetic predisposition70%85%1 minuteRisk stratification

🎯 The Clinical Mastery Arsenal: Rapid-Fire Diagnostic Tools

Practice Questions: Hair and Nail Disorders

Test your understanding with these related questions

Finasteride is classified as a:

1 of 5

Flashcards: Hair and Nail Disorders

1/10

_____ hair are often seen at the margins of the bald patches during active phases of alopecia areata

TAP TO REVEAL ANSWER

_____ hair are often seen at the margins of the bald patches during active phases of alopecia areata

Exclamation mark

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial